Key Details
Symbol (NSE): SAGCEM
Corporate Action: Scheme of Amalgamation
Nature of Scheme: Amalgamation of Andhra Cements Limited (Transferor Company) with and into Sagar Cements Limited (Transferee Company)
Entities Involved:
- Transferor Company: Andhra Cements Limited (ACL)
- Transferee Company: Sagar Cements Limited (SCL)
Share Entitlement Ratio: Not Specified
Implied Capital Structure Impact: Not Specified
Post-Allotment Listing Plan: Not Specified
Record Date: Not Specified
Effective Date: Not Specified
Regulatory and Approval Status
Current Status: Received Observation Letters from BSE and NSE
- BSE Letter Date: 05 November 2026 (Reference: DCS/AMAL/RD/R37/323/2026-27)
- NSE Letter Date: 06 November 2026 (Reference: NSE/LIST/55832/55833)
- BSE Stance: 'No adverse observations'
- NSE Stance: 'No objection'
Approval Requirements: Subject to statutory and regulatory approvals under applicable laws, including approval of the NCLT
Validity of Observation Letters: Six months from date of issuance (until May 2027)
SEBI Comments and Requirements
SEBI provided 21 specific comments/requirements through its letter dated 30 October 2026:
1. Disclosure of all ongoing adjudication, recovery proceedings, prosecution initiated, and enforcement actions against companies, promoters, and directors
2. Scheme made expressly subject to receipt of NOC from lending scheduled commercial banks/financial institutions
3. Scheme made expressly subject to receipt of report on complaints and necessary measures
4. Display of additional information submitted after filing on company and exchange websites
5. Compliance with SEBI circulars issued from time to time
6. Transfer of all liabilities of transferor company to transferee company
7. Inclusion of unlisted company information in abridged prospectus format (Part E of Schedule VI of ICDR Regulations, 2018)
8. Financials in scheme including valuation report not more than 6 months old
9. Prominent disclosure of proposed scheme details in shareholder notice
10. Comprehensive explanatory statement including:
- Need, rationale, synergies, impact on shareholders, cost-benefit analysis
- Details of Registered Valuer and Merchant Banker with valuation methodology
- Basis for share swap ratio
- Pre and post scheme shareholding patterns
- Capital built-up since incorporation and last 3 years
- Revenue, PAT, EBITDA for last 3 years
- Value of assets and liabilities being transferred and post-merger balance sheet
- Potential benefits and risks
- Financial implications on promoters, public shareholders, and future growth prospects
- Part B of Schedule I of SEBI (Issue and Listing of Non-Convertible Securities) Regulations, 2021 for NCD/NCRPS holders
11. Disclosure of all pending actions against entities involved
12. Inclusion of additional information submitted to SEBI as part of shareholder disclosures
13. Equity shares issued under Scheme to be in demat form only
14. Scheme subject to compliance with relevant clauses in scheme document
15. No misstatement or false information in disclosures
16. No changes to draft scheme without specific written consent of SEBI
17. Incorporation of SEBI/Exchange observations in NCLT petition
18. Compliance with Companies Act, 2013 including creditor consent
19. Petitions to be filed with NCLT after processing of draft scheme by SEBI/Exchange
20. Disclosure of No-Objection letter on company website within 24 hours of receipt
21. Clarification that submission doesn't constitute SEBI clearance or approval
Additional Requirements
- BSE requires all notices under Section 230(5) or Section 66 of Companies Act, 2013 to be served through BSE Listing Centre online system only (no physical filings)
- NSE specifies that companies are not required to send notice for representation under section 230(5) to NSE again after processing of draft scheme
- Companies must file compliance status report stating compliance with each point of Observation Letter
Financial Rationale
Not Specified
Impact on Shareholders
Not Specified